Latest Expansion News

Vaughan Nelson Global Equity SMID Fund delivered a sharp rise in operating profit and more than quadrupled its net assets in FY2026, helped by $31.8 million in investment gains and strong investor applications. The result also leaves the ASX-listed Class B units with greater exposure to global equity and currency movements.

Aspire Mining has retained the Ovoot project’s 130.1 million-tonne JORC Coal Reserve while redesigning how the Mongolian mine is funded and built. The refreshed model forecasts a US$1.48 billion post-tax NPV10, but depends on debt raising, infrastructure delivery and a 12% Inferred Resource contribution to planned output.

JB Hi-Fi delivered record FY2026 sales of $11.06 billion and lifted its fully franked ordinary dividend by 22.5% to 337 cents per share. The early FY2027 trading update was less assured, with Australian sales and The Good Guys declining in July as shoppers waited for promotions and technology supply remained constrained.

Tivan has secured the regulatory and cultural heritage clearances needed to advance an 8,000-metre drilling campaign at its Molyhil tungsten project in the Northern Territory. The company will also issue 3.84 million shares as part-payment for the project acquisition, while its feasibility and proposed funding plans remain unfinished.

Blackpearl Group more than doubled annual recurring revenue to NZ$26.8 million in FY26, but the growth came alongside an NZ$17.8 million loss and a formal material uncertainty over its ability to continue as a going concern. The company says cost reductions, faster cash conversion and its refinanced BNZ facility can support the next phase.

Pathkey.AI has appointed Nanyang Technological University chip design and AI specialist Professor Anupam Chattopadhyay to the new Advisory Board supporting Chipforge. The appointment adds technical and commercialisation experience as the AI-native semiconductor platform moves from development towards a product launch, although no launch date or commercial contract was disclosed.

Bubs Australia has secured permanent US FDA authorisation for three infant formula products, removing a regulatory barrier in the company’s largest market. The approval supports possible portfolio expansion and contract manufacturing, but the presentation contains no new earnings guidance or quantified financial benefit.

Emyria has secured a limited in-person speaking position at a US FDA hearing examining how psychedelic medicines could be delivered safely and at scale. The appearance gives the ASX-listed company a regulatory platform, but does not represent FDA approval, funding or a commercial agreement.

PM Capital Global Opportunities Fund has completed a $172 million share purchase plan, with all valid applications accepted in full. About 56 million new shares will be issued at $3.07 each and qualify for PGF’s upcoming fully franked dividend.

Eureka Group Holdings has secured $70.7 million from institutional investors to help fund its $123.8 million acquisition of six NSW communities. The remaining $9.5 million retail offer opens against a backdrop of upgraded FY27 earnings guidance, but also higher gearing and execution risk.

Eagers Automotive has signed a non-binding agreement to acquire a 50% interest in Zagame Automotive Group, gaining exposure to 14 premium and luxury vehicle brands across Melbourne and Adelaide. The company expects the proposed joint venture to be immediately earnings accretive, although completion remains conditional and no transaction value has been disclosed.

Ore Resources has extended lithium mineralisation beyond the current resource boundaries at its Big Red and Potoroo pegmatites, with drilling still open to the north and west. The results add exploration upside to Kangaroo Hills as the company advances strategic discussions and approvals for a potential DSO operation.